Histone methyltransferases and demethylases: regulators in balancing osteogenic and adipogenic differentiation of mesenchymal stem cells

International Journal of Oral Science

Volumn 7, Issue 4, 2015, Pages 197-204

  Deng, Peng ^a,b   Chen, Qian Ming ^b   Hong, Christine ^a   Wang, Cun Yu ^a,c  

^a UCLA SCHOOL OF DENTISTRY   (United States)

^b SICHUAN UNIVERSITY   (China)

^c Engineering IV   (United States)

Author keywords

adipogenesis; histone lysine demethylase; histone lysine methyltransferase; histone methylation; mesenchymal stem cells; osteogenesis

Indexed keywords

F BOX PROTEIN; HISTONE DEMETHYLASE; HISTONE LYSINE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE; KDM2A PROTEIN, HUMAN; METHYLTRANSFERASE; SU(VAR)3-9;

ADIPOGENESIS; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LINEAGE; ENZYMOLOGY; GENETIC EPIGENESIS; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; PHYSIOLOGY;

ADIPOGENESIS; CELL DIFFERENTIATION; CELL LINEAGE; EPIGENESIS, GENETIC; F-BOX PROTEINS; HISTONE DEMETHYLASES; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; MESENCHYMAL STROMAL CELLS; METHYLTRANSFERASES; OSTEOGENESIS;

EID: 85016295780     PISSN: 16742818     EISSN: 20493169     Source Type: Journal    
DOI: 10.1038/IJOS.2015.41     Document Type: Review

References (104)

1. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007; 213(2): 341–347.
2. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8(4): 315–317.
3. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008; 2(4): 313–319.
4. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med (Maywood) 2001; 226(6): 507–520.
5. Romanov YA, Darevskaya AN, Merzlikina NV et al. Mesenchymal stem cells from human bone marrow and adipose tissue: isolation, characterization, and differentiation potentialities. Bull Exp Biol Med 2005; 140(1): 138–143.
6. Ma S, Xie N, Li W et al. Immunobiology of mesenchymal stem cells. Cell Death Differ 2014; 21(2): 216–225.
7. Ren G, Su J, Zhang L et al. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 2009; 27(8): 1954–1962.
8. James AW. Review of signaling pathways governing MSC osteogenic and adipogenic differentiation. Scientifica (Cairo) 2013; 2013: 684736.
9. Dragojevič J, Logar DB, Komadina R et al. Osteoblastogenesis and adipogenesis are higher in osteoarthritic than in osteoporotic bone tissue. Arch Med Res 2011; 42(5): 392–397.
10. Hoshiba T, Kawazoe N, Chen G. The balance of osteogenic and adipogenic differentiation in human mesenchymal stem cells by matrices that mimic stepwise tissue development. Biomaterials 2012; 33(7): 2025–2031.
11. Johnston CC Jr, Bjarnason NH, Cohen FJ et al. Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials. Arch Intern Med 2000; 160(22): 3444–3450.
12. Chang J, Wang Z, Tang E et al. Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med 2009; 15(6): 682–689.
13. Moerman EJ, Teng K, Lipschitz DA et al. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-c2 transcription factor and TGF-b/BMP signaling pathways. Aging Cell 2004; 3(6): 379– 389.
14. Takada I, Kouzmenko AP, Kato S. Wnt and PPARc signaling in osteoblasto genesis and adipogenesis. Nat Rev Rheumatol 2009; 5(8): 442–447.
15. Lin GL, Hankenson KD. Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. J Cell Biochem 2011; 112(12): 3491–3501.
16. Chang J, Liu F, Lee M et al. NF-kB inhibits osteogenic differentiation of mesenchymal stem cells by promoting b-catenin degradation. Proc Natl Acad Sci U S A 2013; 110(23): 9469–9474.
17. Lim KE, Park NR, Che X et al. Core binding factor b of osteoblasts maintains cortical bone mass via stabilization of Runx2 in mice. J Bone Miner Res 2015; 30(10): 1943.
18. Chawla A, Schwarz EJ, Dimaculangan DD et al. Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 1994; 135(2): 798–800.
19. Johansson C, Tumber A, Che K et al. The roles of Jumonji-type oxygenases in human disease. Epigenomics 2014; 6(1): 89–120.
20. Pedersen MT, Helin K. Histone demethylases in development and disease. Trends Cell Biol 2010; 20(11): 662–671.
21. Pasini D, Bracken AP, Agger K et al. Regulation of stem cell differentiation by histone methyltransferases and demethylases. Cold Spring Harb Symp Quant Biol 2008; 73: 253–263.
22. Wu H, Sun YE. Epigenetic regulation of stem cell differentiation. Pediatr Res 2006; 59(4 Pt 2): 21R–215R.
23. Jenuwein T, Allis CD. Translating the histone code. Science 2001; 293(5532): 1074–1080.
24. Lunyak VV, Rosenfeld MG. Epigenetic regulation of stem cell fate. Hum Mol Genet 2008; 17(R1): R28–R36.
25. Klose RJ, Zhang Y. Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol 2007; 8(4): 307–318.
26. Min J, Feng Q, Li Z et al. Structure of the catalytic domain of human DOT1L, a non-SET domain nucleosomal histone methyltransferase. Cell 2003; 112(5): 711–723.
27. Patel A, Vought VE, Dharmarajan V et al. A novel non-SET domain multi-subunit methyltransferase required for sequential nucleosomal histone H3 methylation by the mixed lineage leukemia protein-1 (MLL1) core complex. J Biol Chem 2011; 286(5): 3359–3369.
28. Allfrey VG, Faulkner R, Mirsky AE. Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci U S A 1964; 51: 786–794.
29. Strahl BD, Ohba R, Cook RG et al. Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc Natl Acad Sci U S A 1999; 96(26): 14967–14972.
30. Dodge JE, Kang YK, Beppu H et al. Histone H3-K9 methyltransferase ESET is essential for early development. Mol Cell Biol 2004; 24(6): 2478–2486.
31. Marmorstein R. Structure of SET domain proteins: a new twist on histone methylation. Trends Biochem Sci 2003; 28(2): 59–62.
32. Yang L, Lawson KA, Teteak CJ et al. ESET histone methyltransferase is essential to hypertrophic differentiation of growth plate chondrocytes and formation of epiphyseal plates. Dev Biol 2013; 380(1): 99–110.
33. Lawson KA, Teteak CJ, Gao J et al. ESET histone methyltransferase regulates osteoblastic differentiation of mesenchymal stem cells during postnatal bone development. FEBS Lett 2013; 587(24): 3961–3967.
34. Liu W, Toyosawa S, Furuichi T et al. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. JCellBiol 2001; 155(1): 157–166.
35. Yasuda R, Okada H, Shirai K et al. Comparison of two pediatric flail chest cases. Scand J Trauma Resusc Emerg Med 2015; 23(1): 73.
36. Alvarez G, González M, Isabal S et al. Method to quantify live and dead cells in multi-species oral biofilm by real-time PCR with propidium monoazide. AMB Express 2013; 3(1): 1.
37. Schwartz YB, Pirrotta V. Polycomb complexes and epigenetic states. Curr Opin Cell Biol 2008; 20(3): 266–273.
38. Pasini D, Bracken AP, Jensen MR et al. Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J 2004; 23(20): 4061–4071.
39. O’Carroll D, Erhardt S, Pagani M et al. The polycomb-group gene Ezh2 is required for early mouse development. Mol Cell Biol 2001; 21(13): 4330–4336.
40. Faust C, Schumacher A, Holdener B et al. The eed mutation disrupts anterior mesoderm production in mice. Development 1995; 121(2): 273–285.
41. Tonini T, D’Andrilli G, Fucito A et al. Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements. J Cell Physiol 2008; 214(2): 295–300.
42. Wei Y, Chen YH, Li LY et al. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat Cell Biol 2011; 13(1): 87–94.
43. Hemming S, Cakouros D, Isenmann S et al. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification. Stem Cells 2014; 32(3): 802–815.
44. Schwarz D, Varum S, Zemke M et al. Ezh2 is required for neural crest-derived cartilage and bone formation. Development 2014; 141(4): 867–877.
45. Wang L, Jin Q, Lee JE et al. Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis. Proc Natl Acad Sci U S A 2010; 107(16): 7317– 7322.
46. Chen YH, Yeh FL, Yeh SP et al. Myocyte enhancer factor-2 interacting transcriptional repressor (MITR) is a switch that promotes osteogenesis and inhibits adipogenesis of mesenchymal stem cells by inactivating peroxisome proliferator-activated receptor gamma-2. J Biol Chem 2011; 286(12): 10671–10680.
47. Oda H, Okamoto I, Murphy N et al. Monomethylation of histone H4-lysine 20 is involved in chromosome structure and stability and is essential for mouse development. Mol Cell Biol 2009; 29(8): 2278–2295.
48. Beck B, Blanpain C. Mechanisms regulating epidermal stem cells. EMBO J 2012; 31(9): 2067–2075.
49. Karachentsev D, Sarma K, Reinberg D et al. PR-Set7-dependent methylation of histone H4 Lys 20 functions in repression of gene expression and is essential for mitosis. Genes Dev 2005; 19(4): 431–435.
50. Wakabayashi K, Okamura M, Tsutsumi S et al. The peroxisome proliferator-activated receptor c/retinoid X receptor a heterodimer targets the histone modification enzyme PR-Set7/Setd8 gene and regulates adipogenesis through a positive feedback loop. Mol Cell Biol 2009; 29(13): 3544–3555.
51. Cristancho AG, Lazar MA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 2011; 12(11): 722–734.
52. Yu BD, Hess JL, Horning SE et al. Altered Hox expression and segmental identity in Mll-mutant mice. Nature 1995; 378(6556): 505–508.
53. Terranova R, Agherbi H, Boned A et al. Histone and DNA methylation defects at Hox genes in mice expressing a SET domain-truncated form of Mll. Proc Natl Acad Sci USA 2006; 103(17): 6629–6634.
54. Lee J, Saha PK, Yang QH et al. Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis. Proc Natl Acad Sci USA 2008; 105(49): 19229–19234.
55. Lee S, Lee DK, Dou Y et al. Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. Proc Natl Acad Sci USA 2006; 103(42): 15392–15397.
56. Dambacher S, Hahn M, Schotta G. Epigenetic regulation of development by histone lysine methylation. Heredity 2010; 105(1): 24–37.
57. Cho YW, Hong S, Jin Q et al. Histone methylation regulator PTIP is required for PPARc and C/EBPa expression and adipogenesis. Cell Metab 2009; 10(1): 27–39.
58. Binda O. On your histone mark, SET, methylate! Epigenetics 2013; 8(5): 457–463.
59. Ge W, Shi L, Zhou Y et al. Inhibition of osteogenic differentiation of human adipose-derived stromal cells by retinoblastoma binding protein 2 repression of RUNX2-activated transcription. Stem Cells 2011; 29(7): 1112–1125.
60. Krivtsov AV, Feng Z, Lemieux ME et al. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell 2008; 14(5): 355–368.
61. Shi Y, Lan F, Matson C et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004; 119(7): 941–953.
62. Martin C, Zhang Y. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 2005; 6(11): 838–849.
63. Lu F, Li G, Cui X et al. Comparative analysis of JmjC domain-containing proteins reveals the potential histone demethylases in Arabidopsis and rice. J Integr Plant Biol 2008; 50(7): 886–896.
64. Lan F, Nottke AC, Shi Y. Mechanisms involved in the regulation of histone lysine demethylases. Curr Opin Cell Biol 2008; 20(3): 316–325.
65. Shi Y. Histone lysine demethylases: emerging roles in development, physiology and disease. Nat Rev Genet 2007; 8(11): 829–833.
66. Tsukada Y, Fang J, Erdjument-Bromage H et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 2006; 439(7078): 811–816.
67. Gao R, Dong R, Du J et al. Depletion of histone demethylase KDM2A inhibited cell proliferation of stem cells from apical papilla by de-repression of p15INK4B and p27Kip1. Mol Cell Biochem 2013; 379(1/2): 115–122.
68. Dong R, Yao R, Du J et al. Depletion of histone demethylase KDM2A enhanced the adipogenic and chondrogenic differentiation potentials of stem cells from apical papilla. Exp Cell Res 2013; 319(18): 2874–2882.
69. He J, Kallin EM, Tsukada Y et al. The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15Ink4b. Nat Struct Mol Biol 2008; 15(11): 1169–1175.
70. Fukuda T, Tokunaga A, Sakamoto R et al. Fbxl10/Kdm2b deficiency accelerates neural progenitor cell death and leads to exencephaly. Mol Cell Neurosci 2011; 46(3): 614–624.
71. Fan Z, Yamaza T, Lee JS et al. BCOR regulates mesenchymal stem cell function by epigenetic mechanisms. Nat Cell Biol 2009; 11(8): 1002–1009.
72. Du J, Ma Y, Ma P et al. Demethylation of epiregulin gene by histone demethylase FBXL11 and BCL6 corepressor inhibits osteo/dentinogenic differentiation. Stem Cells 2013; 31(1): 126–136.
73. Labbé RM, Holowatyj A, Yang ZQ. Histone lysine demethylase (KDM) subfamily 4: structures, functions and therapeutic potential. Am J Transl Res 2013; 6(1): 1–15.
74. Lorbeck MT, Singh N, Zervos A et al. The histone demethylase Dmel\Kdm4A controls genes required for life span and male-specific sex determination in Drosophila. Gene 2010; 450(1–2): 8–17.
75. Iwamori N, Zhao M, Meistrich ML et al. The testis-enriched histone demethylase, KDM4D, regulates methylation of histone H3 lysine 9 during spermatogenesis in the mouse but is dispensable for fertility. Biol Reprod 2011; 84(6): 1225–1234.
76. Pedersen MT, Agger K, Laugesen A et al. The demethylase JMJD2C localizes to H3K4me3-positive transcription start sites and is dispensable for embryonic development. Mol Cell Biol 2014; 34(6): 1031–1045.
77. Kawazu M, Saso K, Tong KI et al. Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development. PLoS One 2011; 6(3): e17830.
78. Verrier L, Escaffit F, Chailleux C et al. A new isoform of the histone demethylase JMJD2A/KDM4A is required for skeletal muscle differentiation. PLoS Genet 2011; 7(6): e1001390.
79. Strobl-Mazzulla PH, Sauka-Spengler T, Bronner-Fraser M. Histone demethylase JmjD2A regulates neural crest specification. Dev Cell 2010; 19(3): 460–468.
80. Ye L, Fan Z, Yu B et al. Histone demethylases KDM4B and KDM6B promotes osteogenic differentiation of human MSCs. Cell Stem Cell 2012; 11(1): 50–61.
81. Guo L, Li X, Huang JX et al. Histone demethylase Kdm4b functions as a co-factor of C/ EBPb to promote mitotic clonal expansion during differentiation of 3T3-L1 preadipocytes. Cell Death Differ 2012; 19(12): 1917–1927.
82. Lu C, Ward PS, Kapoor GS et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 2012; 483(7390): 474–478.
83. Vandamme J, Lettier G, Sidoli S et al. The C. elegans H3K27 demethylase UTX-1 is essential for normal development, independent of its enzymatic activity. PLoS Genet 2012; 8(5): e1002647.
84. Shpargel KB, Sengoku T, Yokoyama S et al. UTX and UTY demonstrate histone demethylase-independent function in mouse embryonic development. PLoS Genet 2012; 8(9): e1002964.
85. Satoh T, Takeuchi O, Vandenbon A et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 2010; 11(10): 936–944.
86. Seenundun S, Rampalli S, Liu QC et al. UTX mediates demethylation of H3K27me3 at muscle-specific genes during myogenesis. EMBO J 2010; 29(8): 1401–1411.
87. Burgold T, Spreafico F, De Santa F et al. The histone H3 lysine 27-specific demethylase Jmjd3 is required for neural commitment. PLoS One 2008; 3(8): e3034.
88. Xu J, Yu B, Hong C et al. KDM6B epigenetically regulates odontogenic differentiation of dental mesenchymal stem cells. Int J Oral Sci 2013; 5(4): 200–205.
89. Sinha KM, Yasuda H, Coombes MM et al. Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase. EMBO J 2010; 29(1): 68–79.
90. Tao Y, Wu M, Zhou X et al. Structural insights into histone demethylase NO66 in interaction with osteoblast-specific transcription factor osterix and gene repression. J Biol Chem 2013; 288(23): 16430–16437.
91. Sinha KM, Yasuda H, Zhou X et al. Osterix and NO66 histone demethylase control the chromatin of Osterix target genes during osteoblast differentiation. J Bone Miner Res 2014; 29(4): 855–865.
92. Christensen J, Agger K, Cloos PA et al. RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell 2007; 128(6): 1063– 1076.
93. Klose RJ, Yan Q, Tothova Z et al. The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 2007; 128(5): 889–900.
94. Benevolenskaya EV, Murray HL, Branton P et al. Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol Cell 2005; 18(6): 623–635.
95. Lopez-Bigas N, Kisiel TA, Dewaal DC et al. Genome-wide analysis of the H3K4 histone demethylase RBP2 reveals a transcriptional program controlling differentiation. Mol Cell 2008; 31(4): 520–530.
96. Pasini D, Hansen KH, Christensen J et al. Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and polycomb-repressive complex 2. Genes Dev 2008; 22(10): 1345–1355.
97. Baba A, Ohtake F, Okuno Y et al. PKA-dependent regulation of the histone lysine demethylase complex PHF2-ARID5B. Nat Cell Biol 2011; 13(6): 668–675.
98. Okuno Y, Ohtake F, Igarashi K et al. Epigenetic regulation of adipogenesis by PHF2 histone demethylase. Diabetes 2013; 62(5): 1426–1434.
99. Binda O, LeRoy G, Bua DJ et al. Trimethylation of histone H3 lysine 4 impairs methylation of histone H3 lysine 9: regulation of lysine methyltransferases by physical interaction with their substrates. Epigenetics 2010; 5(8): 767–775.
100. Wang H, Cao R, Xia L et al. Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol Cell 2001; 8(6): 1207–1217.
101. Fischle W, Wang Y, Allis CD. Histone and chromatin cross-talk. Curr Opin Cell Biol 2003; 15(2): 172–183.
102. Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res 2011; 21(3): 381–395.
103. Shukla A, Chaurasia P, Bhaumik SR. Histone methylation and ubiquitination with their cross-talk and roles in gene expression and stability. Cell Mol Life Sci 2009; 66(8): 1419–1433.
104. Shen X, Kim W, Fujiwara Y et al. Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 2009; 139(7): 1303–1314.